Emerging nano-based strategies against drug resistance in tumor chemotherapy
L Cao, Y Zhu, W Wang, G Wang, S Zhang… - … in bioengineering and …, 2021 - frontiersin.org
Drug resistance is the most significant causes of cancer chemotherapy failure. Various
mechanisms of drug resistance include tumor heterogeneity, tumor microenvironment …
mechanisms of drug resistance include tumor heterogeneity, tumor microenvironment …
Application of stimuli responsive nanocomposites in drug delivery and theranostics to counter cancer proliferation and drug resistance
Ingenious nanomedical researches have ameliorated outcomes in cancer theranostics.
Though limitations like non specific distribution generating low signal to noise ratio in …
Though limitations like non specific distribution generating low signal to noise ratio in …
Polymeric dendrimers as nanocarrier vectors for neurotheranostics
Dendrimers are polymers with well‐defined 3D branched structures that are vastly utilized in
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …
Recent progress and advances of multi-stimuli-responsive dendrimers in drug delivery for cancer treatment
NTT Le, TNQ Nguyen, VD Cao, DT Hoang, VC Ngo… - Pharmaceutics, 2019 - mdpi.com
Despite the fact that nanocarriers as drug delivery systems overcome the limitation of
chemotherapy, the leakage of encapsulated drugs during the delivery process to the target …
chemotherapy, the leakage of encapsulated drugs during the delivery process to the target …
Self-assembling ferritin-dendrimer nanoparticles for targeted delivery of nucleic acids to myeloid leukemia cells
F Palombarini, S Masciarelli, A Incocciati… - Journal of …, 2021 - Springer
Background In recent years, the use of ferritins as nano-vehicles for drug delivery is taking
center stage. Compared to other similar nanocarriers, Archaeoglobus fulgidus ferritin is …
center stage. Compared to other similar nanocarriers, Archaeoglobus fulgidus ferritin is …
Drug delivery of siRNA therapeutics
G Lamberti, AA Barba - Pharmaceutics, 2020 - mdpi.com
Small interfering RNA (siRNA) is a class of nucleic acid-based drugs (NABDs) able to block
gene expression by interaction with mRNA before its translation. Small interfering RNAs …
gene expression by interaction with mRNA before its translation. Small interfering RNAs …
Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer
Triple‐negative breast cancer develops from malignant cells within the interior lining of milk
ducts or, less frequently, in the stromal tissues and accounts for≈ 15% of all breast cancers …
ducts or, less frequently, in the stromal tissues and accounts for≈ 15% of all breast cancers …
Cationic dendrimers for siRNA delivery: an overview of methods for in vitro/in vivo characterization
This chapter reviews the different techniques for analyzing the chemical-physical properties,
transfection efficiency, cytotoxicity, and stability of covalent cationic dendrimers (CCDs) and …
transfection efficiency, cytotoxicity, and stability of covalent cationic dendrimers (CCDs) and …
Development and characterization of temozolomide-PAMAM-siRNA dendriplexes for the effective management of glioblastoma multiforme
This study was aimed to develop and evaluate the TMZ-PAMAM-siRNA [temozolomide-
polyamidoamine dendimer-siRNA] dendriplexes for the effective treatment of glioblastoma …
polyamidoamine dendimer-siRNA] dendriplexes for the effective treatment of glioblastoma …
Evolution from covalent to self-assembled PAMAM-based dendrimers as nanovectors for siRNA delivery in cancer by coupled in silico-experimental studies. Part II …
In part I of this review, the authors showed how poly (amidoamine)(PAMAM)-based
dendrimers can be considered as promising delivering platforms for siRNA therapeutics …
dendrimers can be considered as promising delivering platforms for siRNA therapeutics …